A Protective Role of Glibenclamide in Inflammation-Associated Injury

• Main Authors: Gensheng Zhang (Author), Xiuhui Lin (Author), Shufang Zhang (Author), Huiqing Xiu (Author), Chuli Pan (Author), Wei Cui (Author)
• 格式: 圖書
• 出版: Hindawi Limited, 2017-01-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Glibenclamide is the most widely used sulfonylurea drug for the treatment of type 2 diabetes mellitus (DM). Recent studies have suggested that glibenclamide reduced adverse neuroinflammation and improved behavioral outcomes following central nervous system (CNS) injury. We reviewed glibenclamide...